Profil bibliographique

Hubert Hackl

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

340Publications signalées

21125Citations signalées

2Affiliations récentes

Institutions déclarées

Innsbruck Medical University Universität Innsbruck

Domaines associés

Cancer Immunotherapy and BiomarkersGene expression and cancer classificationCancer Genomics and DiagnosticsMicroRNA in disease regulationHepatocellular Carcinoma Treatment and Prognosis

Publications récentes

Accès ouvert 2026 articleOpenAlex

Long-term follow-up of a phase 1/2 trial of anti-GDF-15 antibody visugromab plus anti-PD-1 antibody nivolumab in anti-PD-1/-L1 relapsed/refractory solid tumors

Ignacio Melero, M. De Miguel, Elena Garralda Cabanas, Guillermo de Velasco et autres

1 citationJournal of Hematology & Oncology

Accès ouvert 2026 articleOpenAlex

Additional file 1 of Long-term follow-up of a phase 1/2 trial of anti-GDF-15 antibody visugromab plus anti-PD-1 antibody nivolumab in anti-PD-1/-L1 relapsed/refractory solid tumors

Ignacio Melero, M. de Miguel, Elena Garralda Cabanas, Guillermo de Velasco et autres

0 citationsFigshare

Accès ouvert 2026 articleOpenAlex

Additional file 1 of Long-term follow-up of a phase 1/2 trial of anti-GDF-15 antibody visugromab plus anti-PD-1 antibody nivolumab in anti-PD-1/-L1 relapsed/refractory solid tumors

Ignacio Melero, M. de Miguel, Elena Garralda Cabanas, Guillermo de Velasco et autres

0 citationsFigshare

2026 conference-abstractOpenAlex

Abstract 6999: GDF-15 inhibition overcomes treatment resistance to platinum- and taxane-based cytotoxic chemoimmunotherapy

Neha Vashist, Amelie Köhler, Daniel Schätzlein, Sabrina Genßler et autres

0 citationsCancer Research

2026 articleOpenAlex

EX VIVO NORUCHOLIC ACID THERAPY DURING NORMOTHERMIC MACHINE PERFUSION IMPROVES VIABILITY AND BILIARY PROTECTION IN MARGINAL HUMAN LIVER GRAFTS

David Pereyra, Jule Dingfelder, Laurin Rauter, Hubert Hackl et autres

0 citationsHPB

Accès ouvert 2025 articleOpenAlex

HTK Is a Viable UW Alternative for Hypothermic Oxygenated Machine Perfusion of Liver Grafts Supporting a Single-Solution Protocol

Jule Dingfelder, David Pereyra, Moriz Riha, Nikolaus Becker et autres

0 citationsJournal of Clinical Medicine

Accès ouvert 2025 articleOpenAlex

The Role of Plasmacytoid Dendritic Cells in the Immune Contexture of TP53-Mutated High-Grade Serous Ovarian Cancer

K. Steger, Heidi Fiegl, Katja Rungger, Katharina Leitner et autres

1 citationCancers

Accès ouvert 2025 articleOpenAlex

Deletion of MMP12 improves energy metabolism and brown adipose tissue function in mice prone to cardiometabolic disease

Melina Amor, Malena Diaz, Alexander Fuerlinger, Monika Svecla et autres

0 citationsJournal of Lipid Research

Accès ouvert 2025 articleOpenAlex

Newly identified oncolytic VSV-GP-specific CD8+ T cell epitopes for monitoring of anti-viral immune responses in the BALB/c mouse model

Sarah Danklmaier, Saskia V Vijver, Lisa Pipperger, Gabriel Floriani et autres

0 citationsMolecular Therapy Oncology

Accès ouvert 2025 articleOpenAlex

PNPLA3 polymorphism worsens chemotherapy associated liver injury and affects overall survival in colorectal cancer patients with liver metastasis undergoing hepatic resection

Benedikt Rumpf, Jonas Santol, A.E. Kern, Markus Ammann et autres

4 citationsEBioMedicine

Accès ouvert 2025 articleOpenAlex

Association of the composition of the bone marrow tumor microenvironment in BCR::ABL1-negative myeloproliferative neoplasms with IFN-γ signaling and driver mutations

Marcus Bauer, Christoforos Vaxevanis, Nadja Jäkel, Hubert Hackl et autres

4 citationsLeukemia

Accès ouvert 2025 articleOpenAlex

Hypothermic Oxygenated Machine Perfusion of Liver Grafts Using HTK (Custodiol©) is an Alternative to Standard Use of UW Machine Perfusion in a Single Solution Strategy

David Pereyra, James R. Dingfelder, Nikolaus Becker, John F. Mueller et autres

0 citationsAmerican Journal of Transplantation

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.